ECU Health's main hospital in Greenville is operating well above capacity, meaning patients could face longer wait times.
The Edison Histotripsy System, approved by the Food and Drug Administration in October 2023, uses ultrasound waves to target and destroy tumor cells while minimizing damage to surrounding tissue.